Authors
R Nallathambi, M Mazuz, A Ion, G Selvaraj, S Weininger, M Fridlender, A Nasser, O Sagee, P Kumari, D Nemichenizer, M Mendelovitz, N Firstein, O Hanin, F Konikoff, Y Kapulnik, T Naftali, H. Koltai
Publication date
2017/7/1
Journal
Cannabis Cannabinoid Res
Volume
2
Issue
1
Pages
167-182
Publisher
Mary Ann Libert Inc.
Description
Introduction: Inflammatory bowel diseases (IBDs) include Crohn's disease, and ulcerative colitis. Cannabis sativa preparations have beneficial effects for IBD patients. However, C. sativa extracts contain hundreds of compounds. Although there is much knowledge of the activity of different cannabinoids and their receptor agonists or antagonists, the cytotoxic and anti-inflammatory activity of whole C. sativa extracts has never been characterized in detail with in vitro and ex vivo colon models.
Material and Methods: The anti-inflammatory activity of C. sativa extracts was studied on three lines of epithelial cells and on colon tissue. C. sativa flowers were extracted with ethanol, enzyme-linked immunosorbent assay was used to determine the level of interleukin-8 in colon cells and tissue biopsies, chemical analysis was performed using high-performance liquid chromatography, mass spectrometry and nuclear magnetic …
Total citations
201820192020202120222023202476181311136